TScan Therapeutics Inc Sustainability Reports
Tscan Therapeutics Inc. is a biotechnology company focused on developing T-cell receptor-engineered T-cell therapies for the treatment of cancer and other diseases.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US89854M1018
2 reports from 2023 to 2024
Company Profile
TScan Therapeutics Inc
Tscan Therapeutics Inc. is a biotechnology company focused on developing T-cell receptor-engineered T-cell therapies for the treatment of cancer and other diseases.
Reports